Dr. Jason Douglas Huff, MD

Dr. Huff practices at High Point Behavioral Health in High Point, North Carolina.

Dr. Huff's NPI, 1245298587, was assigned on May 3, 2006. Dr. Huff graduated from University of Nebraska College of Medicine in 2000. Dr. Huff holds North Carolina license 200300996.

Dr. Huff's primary practice is High Point Behavioral Health, at 601 North Elm Street, High Point, NC 27261. The practice phone is (800) 525-9375.

Dr. Huff's primary practice is High Point Behavioral Health in High Point, North Carolina. Dr. Huff is also affiliated with High Point Medical Center. The medical group on file is Atrium Health Wake Forest Baptist. Dmand AI also links Dr. Huff to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Huff practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Huff's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Huff's licenses on file in 2 states: North Carolina and Colorado.

CMS data shows 531 Medicare services from Dr. Huff across 5 procedure codes in 2024, all of them office visits, for 171 Medicare patients. Medicare paid $43,703 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 171 Medicare patients who saw Dr. Huff in 2024. The largest group is 65 to 74, with 69 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Huff's median patient age at 73, with 59% women.

In 2024, Dr. Huff wrote 2,464 Medicare Part D claims for 276 patients. 75% of them were for generic drugs. CMS names the drug for 2,050 of them, across 57 drugs with 11 or more claims each, at $3,575,234 in total drug cost. In 2023, CMS named 1,761 claims across 46 drugs.

Dr. Huff accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Huff to 4 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating, Small Cell Lung Carcinoma and Breast Carcinoma In Situ. SWOG Cancer Research Network sponsors the most, 3.

CMS Open Payments shows 44 general payments to Dr. Huff from 20 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 98% of the total. Celgene Corporation paid the most, $181.

Dr. Huff graduated from University of Nebraska College of Medicine in 2000.